1-5 of 5
Eva Cavallin-Ståhl
Close
Sort by
Journal Articles

Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Esa Jantunen, Thomas Relander, Grete Fossum Lauritzsen, MD, Hans Hagberg, MD, Harald Anderson, PhD, Eva Cavallin-Ståhl, MD, Harald Holte, Anders Østerborg, MD, Mats Merup, MD, Peter De Nully Brown, MD, Outi Kuittinen, MD, Martin Erlanson, MD, Bj∅rn Østenstad, MD, Unn-Merete Fagerli, MD, Ole Gadeberg, MD, Christer Sundstrom, MD, PhD, Jan Delabie, MD, Elisabeth Ralfkiaer, MD, Martine Vornanen, MD, Francesco d’Amore
Journal: Blood
Blood (2010) 116 (21): 3565.
https://doi.org/10.1182/blood.V116.21.3565.3565
Published: 2010
Journal Articles

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Thomas Relander, MD, Grete Fossum Lauritzsen, MD, Esa Jantunen, MD, Hans Hagberg, MD, Harald Anderson, PhD, Eva Cavallin-Ståhl, MD, Harald Holte, MD, Anders Østerborg, MD, Mats Merup, MD, Peter De Nully Brown, MD, Bj∅rn Østenstad, MD, Outi Kuittinen, MD, Martin Erlanson, MD, Unn-Merete Fagerli, MD, Ole Gadeberg, MD, Christer Sundstrom, MD, PhD, Jan Delabie, MD, Elisabeth Ralfkiaer, MD, Martine Vornanen, MD, Francesco d’Amore
Journal: Blood
Blood (2010) 116 (21): 3566.
https://doi.org/10.1182/blood.V116.21.3566.3566
Published: 2010
Journal Articles

Genes and Proteins Associated with the Tumor Microenvironment Are Differentially Expressed in Cured Versus Primary Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma.

Johan Linderoth, MD, Patrik Edén, PhD, Mats Ehinger, MD PhD, Jeanette Valcich, Mats Jerkeman, MD PhD, Pär-Ola Bendahl, PhD, Mattias Berglund, PhD, Gunilla Enblad, MD PhD, Martin Erlanson, MD PhD, Göran Roos, MD PhD, Eva Cavallin-Ståhl, MD PhD
Journal: Blood
Blood (2007) 110 (11): 3171.
https://doi.org/10.1182/blood.V110.11.3171.3171
Published: 2007
Journal Articles

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

Francesco d’Amore, MD, Thomas Relander, MD, Grete Lauritzsen, MD, Esa Jantunen, MD, Hans Hagberg, MD, Harald Anderson, PhD, Eva Cavallin-Ståhl, MD, Harald Holte, MD, Anders Østerborg, MD, Mats Merup, MD, Mads Hansen, MD, Ragnar Telhaug, MD, Martin Erlanson, MD, Outi Kuittinen, MD, Ole Gadeberg, MD, Jan Delabie, MD, Christer Sundström, MD, Elisabeth Ralfkiær, MD, Martine Vornanen, MD, Charlotte B. Jensen, MD
Journal: Blood
Blood (2006) 108 (11): 401.
https://doi.org/10.1182/blood.V108.11.401.401
Published: 2006
Journal Articles

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome

Clinical Trials & Observations
Jeanette Lundin, Hans Hagberg, Roland Repp, Eva Cavallin-Ståhl, Susanne Fredén, Gunnar Juliusson, Eija Rosenblad, Geir Tjønnfjord, Tom Wiklund, Anders Österborg
Journal: Blood
Blood (2003) 101 (11): 4267–4272.
https://doi.org/10.1182/blood-2002-09-2802
Published: 2003